References
- McKinlay S M, Brambilia P J, Posner J G. The normal menopause transition. Maturitas 1992; 14: 103–115
- Hlatky M A, Boothroyd D, Vittinghoff E. Quality of life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/progestin Replacement Study (HERS) trial. JAMA 2002; 287: 591–597
- Report of a WHO Scientific Group. Research on the Menopause in the 1990s. World Health Organization, Geneva 1996, WHO technical report series 866
- Nachtigall L E. The symptoms of perimenopause. Clin Obstet Gynecol 1998; 41: 921–927
- Gold E B, Bromberger J, Crawford S, Samuels S, Greendale G A, Harlow S D. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 2001; 153: 865–874
- National Bureau of Statistics of China. 2001 China Population. Beijing 2002
- Xu Ling, Zhao Heng, Ge Qinsheng, et al. Epidemiologic study of perimenopause. J Reprod Med 1993; 2: 23–27, [Chinese]
- Zhao Gengli, Wang Linhong, Zhang Wenkun, et al. Survey of menopausal knowledge, attitude and behavior of women living in Northern China. J Healthy Education in China 2002; 18: 1–4, [Chinese]
- Huang W, Peng W, Wu Y, et al. The status quo of perimenopausal and postmenopausal women in Chengdu: report of a population-based cross-sectional study. Sichuan Da Xue Xue Bao Yi Xue Ban 2003; 34: 536–538, [Chinese]
- Lu H B, Yang X C, Huang Y X. Perimenopausal epidemiological survey in Nanning. Guangxi Yi Ke Da Xue Xue Bao 2001; 18: 761–763, [Chinese]
- Carla M O. Menopause across culture: a review of the evidence. Menopause 2000; 7: 184–192
- Harvey Chim, Bee Tan Huat Iain, Chia Ang Chun, et al. The prevalence of menopausal symptoms in a community in Singapore. Maturitas 2002; 41: 275–282
- Carla M O, Michelle S, Najia H, et al. Menopause in Morocco: symptomatology and medical management. Maturitas 2002; 41: 87–95
- Lam P M, Leung T N, Haines C, et al. Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40–60 years. Maturitas 2003; 45: 99–107
- Lawlor D A, Ebrahim S, Smith G D. The association of socio-economic position across the life course and age at menopause: the British Women's Heart and Health Study. Br J Obstet Gynaecol 2003; 110: 1078–1087
- Rödström K, Bengtsson C, Lissner L, Milsom I, Sundh V, Björkelund C. A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 2002; 9: 156–161
- Whelan E A, Sandler D P. Menstrual and reproductive characteristics and age at natural menopause. Am J Epidemiol 1990; 131: 625–632
- Kasuga M, Makita K, Ishitani K, et al. Relation between climacteric symptoms and ovarian hypofunction in middle-aged and older Japanese women. Menopause 2004; 11: 631–638
- Dennerstein L, Smith A M, Morse C, et al. Menopausal symptoms in Australian women. Med J Aust 1993; 159: 232–236
- Dennerstein L, Dudley E C, Hopper J L, et al. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000; 96: 351–358
- Kuh D L, Wadsworth M, Hardy R. Women's health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynaecol 1997; 104: 923–933
- Gold E B, Sternfeld B, Kelsey J L, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol 2000; 152: 463–473
- Kuh D, Hardy R, Wadsworth M. Social and behavioural influences on the uptake of hormone replacement therapy among younger women. Br J Obstet Gynaecol 2000; 107: 731–739
- Stevenson J C, Lees B, Devenport M, Cust M P, Ganger K F. Determinants of bone density in normal women: risk factors for future osteoporosis?. BMJ 1989; 298: 924–928
- Qingxue Zhang, Dongzi Yang, Wenjun Wang, et al. The analysis of aging, women's bone density and its relevant factors. Chin J Osteoporos 2005; 11: 68–70